Skip to content
AnalystLens

TransDigm Group 8-K Report, Corporate Update (Jul 31, 2024)

Reports
Other Events·Exhibits & Filings
Filing Date
Filed July 31, 2024
Period End
July 31, 2024
Security
TDG
In the record · 2016–202610-K1210-Q338-K234

TDG filed 12 annual reports (10-K), 33 quarterly reports (10-Q) and 234 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Mar ’19Mar ’19
  2. Deal closed8-K · Jan ’21Jan ’21
  3. Material agreement8-K · Jul ’22Jul ’22
  4. Material agreement8-K · Sep ’26Sep ’26

01—Abstract

Summary

Summary of the 8-K filed July 31, 2024. Cited figures are marked; the original filing is the authoritative source.

TransDigm Group (NYSE: TDG) disclosed in this Form 8-K, filed July 31, 2024, that it completed its acquisition of Raptor Labs Holdco, LLC ("Raptor Scientific"), a portfolio company of L Squared Capital Partners, for approximately $655 milliona in cash, including certain tax benefits.

TransDigm funded the deal with cash on hand, so no new debt or equity issuance was reported. The acquisition was first announced in a May 28, 2024 Form 8-K, so this filing confirms closing rather than introducing a new transaction. Raptor Scientific is described as a leading global manufacturer of complex test and measurement solutions, primarily serving aerospace and defense end markets.

The company says nearly all of its revenue comes from proprietary products with significant aftermarket content. It expects about $90 millionb in revenue for calendar 2024 and employs roughly 170 people across five U.S. manufacturing sites in Livermore and Woodland Hills (CA), Berlin (CT), Huntsville (AL), and Peterborough (NH). Based on these figures, the deal implies a purchase price of roughly 7x expected 2024 revenue, though the filing does not disclose earnings, margins, or the value of the tax benefits.

For investors, the deal is modest in scale relative to TransDigm's business. It adds proprietary, aftermarket-heavy test and measurement capabilities that fit TransDigm's model of acquiring highly engineered aerospace and defense components.

The filing does not provide guidance changes, pro forma financials, or updated outlook. Investors should watch future disclosures for integration progress, contribution to margins and cash flow, and any financial details management provides on earnings calls.

02—Key points

Key Highlights

  1. TransDigm completed its acquisition of Raptor Labs Holdco, LLC (Raptor Scientific) on July 31, 2024, for approximately $655 million in cash, including certain tax benefits.
  2. The purchase was funded entirely with cash on hand, with no new debt or equity financing disclosed.
  3. Raptor Scientific is a global manufacturer of complex test and measurement solutions for aerospace and defense, with nearly all revenue from proprietary products.
  4. The target expects approximately $90 million in revenue for calendar 2024, implying roughly 7x expected revenue at the purchase price.
  5. Raptor Scientific employs about 170 people across manufacturing sites in California, Connecticut, Alabama, and New Hampshire.
  6. The deal was first announced via Form 8-K on May 28, 2024; this filing reports closing and attaches the press release as Exhibit 99.1.
  7. The filing does not disclose target earnings, margins, purchase accounting details, or any change to TransDigm's guidance.

03—Questions

Frequently Asked Questions

  1. How large is this acquisition for TransDigm?

    The acquisition cost approximately $655 million in cash, including certain tax benefits. That is a modest deal size relative to TransDigm's overall operations, and it was funded from cash on hand rather than new borrowings.

  2. What does Raptor Scientific do?

    Raptor Scientific manufactures complex test and measurement solutions, primarily for aerospace and defense customers. Its products are highly engineered and proprietary, with significant aftermarket content, which fits TransDigm's strategy of owning sole-source aerospace components.

  3. What is the expected financial contribution of the target?

    The company expects roughly $90 million in revenue for calendar 2024. The filing does not provide EBITDA, margins, or net income, so investors cannot yet assess the profitability of the acquisition from this document.

  4. Did this filing change TransDigm's financial outlook or debt position?

    No guidance change or new financing was reported. The acquisition was paid for with cash on hand, and the filing contains no updated outlook, pro forma financials, or new debt.

  5. Why did the company file this 8-K if the deal was already announced?

    The original agreement was reported on May 28, 2024. This July 31, 2024 filing reports the completion of the transaction and furnishes the closing press release as Exhibit 99.1 under Item 8.01 (Other Events).

04—Continue

← View all 8-K filings